About Transcription factor E2F1
Transcription factor E2F1 (E2F1) is a protein
from Homo sapiens identified by UniProt accession
Q01094, 437 residues long.
MolForge cross-references it against 0 known binders and
267 disease associations.
Target properties
| Protein name | Transcription factor E2F1 |
| UniProt accession | Q01094 |
| Gene | E2F1 |
| Organism | Homo sapiens |
| Length | 437 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (267)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.44
- multiple sclerosis · score 0.30
- Parkinson disease · score 0.30
- Alzheimer disease · score 0.30
- lysosomal storage disease · score 0.30
- lung adenocarcinoma · score 0.29
- endometrial cancer · score 0.29
- head and neck squamous cell carcinoma · score 0.29
- breast adenocarcinoma · score 0.29
- small cell lung carcinoma · score 0.29
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q01094-F1 | alphafold | PREDICTED | 62.03 | — |
Amino-acid sequence (437 residues)
MALAGAPAGG PCAPALEALL GAGALRLLDS SQIVIISAAQ DASAPPAPTG PAAPAAGPCD PDLLLFATPQ APRPTPSAPR PALGRPPVKR RLDLETDHQY LAESSGPARG RGRHPGKGVK SPGEKSRYET SLNLTTKRFL ELLSHSADGV VDLNWAAEVL KVQKRRIYDI TNVLEGIQLI AKKSKNHIQW LGSHTTVGVG GRLEGLTQDL RQLQESEQQL DHLMNICTTQ LRLLSEDTDS QRLAYVTCQD LRSIADPAEQ MVMVIKAPPE TQLQAVDSSE NFQISLKSKQ GPIDVFLCPE ETVGGISPGK TPSQEVTSEE ENRATDSATI VSPPPSSPPS SLTTDPSQSL LSLEQEPLLS RMGSLRAPVD EDRLSPLVAA DSLLEHVRED FSGLLPEEFI SLSPPHEALD YHFGLEEGEG IRDLFDCDFG DLTPLDF
Explore Transcription factor E2F1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets